A detailed history of National Bank Of Canada transactions in Quest Diagnostics Inc stock. As of the latest transaction made, National Bank Of Canada holds 81,884 shares of DGX stock, worth $11.2 Million. This represents 0.02% of its overall portfolio holdings.

Number of Shares
81,884
Previous 31,104 163.26%
Holding current value
$11.2 Million
Previous $4.26 Million 163.68%
% of portfolio
0.02%
Previous 0.01%

Shares

12 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 12, 2024

BUY
$137.09 - $137.09 $6.96 Million - $6.96 Million
50,780 Added 163.26%
81,884 $11.2 Million
Q2 2024

Aug 02, 2024

BUY
$125.91 - $144.34 $758,607 - $869,648
6,025 Added 24.02%
31,104 $4.26 Million
Q1 2024

May 13, 2024

SELL
$123.78 - $142.11 $9.55 Million - $11 Million
-77,179 Reduced 75.47%
25,079 $3.34 Million
Q4 2023

Feb 06, 2024

BUY
$120.62 - $141.12 $8.55 Million - $10 Million
70,922 Added 226.33%
102,258 $14.1 Million
Q3 2023

Oct 10, 2023

BUY
$121.86 - $144.92 $745,052 - $886,040
6,114 Added 24.24%
31,336 $3.82 Million
Q2 2023

Jul 26, 2023

BUY
$130.56 - $146.84 $1.41 Million - $1.59 Million
10,807 Added 74.97%
25,222 $3.55 Million
Q1 2023

Apr 12, 2023

BUY
$131.53 - $155.76 $530,460 - $628,180
4,033 Added 38.85%
14,415 $2.04 Million
Q4 2022

Jan 24, 2023

BUY
$123.31 - $157.26 $23,428 - $29,879
190 Added 1.86%
10,382 $0
Q3 2022

Oct 13, 2022

SELL
$121.77 - $141.1 $287,498 - $333,137
-2,361 Reduced 18.81%
10,192 $1.28 Million
Q2 2022

Jul 28, 2022

BUY
$127.07 - $145.39 $4,066 - $4,652
32 Added 0.26%
12,553 $1.71 Million
Q1 2022

May 05, 2022

BUY
$129.09 - $164.35 $84,424 - $107,484
654 Added 5.51%
12,521 $1.73 Million
Q4 2021

Jan 24, 2022

BUY
$140.36 - $173.01 $1.67 Million - $2.05 Million
11,867 New
11,867 $1.89 Million

Others Institutions Holding DGX

About QUEST DIAGNOSTICS INC


  • Ticker DGX
  • Exchange NYSE
  • Sector Healthcare
  • Industry Diagnostics & Research
  • Shares Outstandng 113,887,000
  • Market Cap $15.6B
  • Description
  • Quest Diagnostics Incorporated provides diagnostic testing, information, and services in the United States and internationally. The company develops and delivers diagnostic information services, such as routine testing, non-routine and advanced clinical testing, anatomic pathology testing, and other diagnostic information services. It offers dia...
More about DGX
Track This Portfolio

Track National Bank Of Canada Portfolio

Follow National Bank Of Canada and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of National Bank Of Canada , based on Form 13F filings with the SEC.

News

Stay updated on National Bank Of Canada with notifications on news.